Suchergebnisse - "Motoi, Noriko"

PubPharm (8)

1

Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients

enthalten in: Clinical lung cancer | 2022

von Shimoda, Y. | Shibaki, R. | Yoshida, T. | +12

2

Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions

enthalten in: Scientific reports | 2021

von Morita, C. | Yoshida, T. | Shirasawa, M. | +11

3

HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs

enthalten in: Thoracic cancer | 2021

von Watanabe, S. | Goto, Y. | Yasuda, H. | +7

4

Disease flare of leptomeningeal metastases without radiological and cytological findings after the discontinuation of osimertinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Takahashi, T. | Umeguchi, H. | Tateishi, A. | +3

5

High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases

enthalten in: Pathology international | 2017

von Mori, S. | Motoi, N. | Ninomiya, H. | +7

ErratumIn: Pathol Int. 2017 Apr;67(4):234. - PMID 28370983

6

Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients : phase II study

enthalten in: Anticancer research | 2013

von Kawano, Y. | Ohyanagi, F. | Yanagitani, N. | +13

ErratumIn: Anticancer Res. 2013 Sep;33(9):4137

7

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2007

von Bean, J. | Brennan, C. | Shih, J. | +20

8

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

enthalten in: The Journal of clinical investigation | 2007

von Gao, S. | Mark, K. | Leslie, K. | +8

CommentIn: J Clin Invest. 2007 Dec;117(12):3660-3. - PMID 18060028

1
[1]